MBX Biosciences (NASDAQ:MBX) executives outlined key clinical and development milestones expected through 2026 during an Oppenheimer life sciences team event featuring CEO Kent Hawryluk and Chief ...
In late 2025 and at the beginning of this year, the Gulf position toward the escalating tensions between the United States and Iran was defined by a refusal to allow the use of Gulf airspace or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results